{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:07:46Z","timestamp":1790392066961,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00330-016-4707-6","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T09:20:55Z","timestamp":1483435255000},"page":"3167-3173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases"],"prefix":"10.1007","volume":"27","author":[{"given":"Julia","family":"Furtner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Berghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.","family":"Albtoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Woitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Asenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Prayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Widhalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gatterbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Birner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Aretin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph C.","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Sch\u00f6pf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"key":"4707_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00401-011-0933-9","volume":"123","author":"M Preusser","year":"2012","unstructured":"Preusser M, Capper D, Ilhan-Mutlu A et al (2012) Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol 123:205\u2013222","journal-title":"Acta Neuropathol"},{"key":"4707_CR2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","volume":"14","author":"L Nayak","year":"2012","unstructured":"Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48\u201354","journal-title":"Curr Oncol Rep"},{"key":"4707_CR3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/neuonc\/now127","volume":"18","author":"ND Arvold","year":"2016","unstructured":"Arvold ND, Lee EQ, Mehta MP et al (2016) Updates in the management of brain metastases. Neuro Oncol 18:1043\u20131065","journal-title":"Neuro Oncol"},{"key":"4707_CR4","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2015-000024","volume":"1","author":"AS Berghoff","year":"2016","unstructured":"Berghoff AS, Schur S, F\u00fcreder LM et al (2016) Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers. ESMO Open 1, e000024","journal-title":"ESMO Open"},{"key":"4707_CR5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","volume":"30","author":"PW Sperduto","year":"2012","unstructured":"Sperduto PW, Kased N, Roberge D et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419\u2013425","journal-title":"J Clin Oncol"},{"key":"4707_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3171\/2013.9.JNS13788","volume":"120","author":"D Kondziolka","year":"2014","unstructured":"Kondziolka D, Parry PV, Lunsford LD et al (2014) The accuracy of predicting survival in individual patients with cancer. J Neurosurg 120:24\u201330","journal-title":"J Neurosurg"},{"key":"4707_CR7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s005200050271","volume":"7","author":"AE Taylor","year":"1999","unstructured":"Taylor AE, Olver IN, Sivanthan T et al (1999) Observer error in grading performance status in cancer patients. Support Care Cancer 7:332\u2013335","journal-title":"Support Care Cancer"},{"key":"4707_CR8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"4707_CR9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629\u2013635","journal-title":"Lancet Oncol"},{"key":"4707_CR10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00330-015-3963-1","volume":"26","author":"D Tamandl","year":"2016","unstructured":"Tamandl D, Paireder M, Asari R et al (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26:1359\u20131367","journal-title":"Eur Radiol"},{"key":"4707_CR11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, MacDonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539\u20131547","journal-title":"J Clin Oncol"},{"key":"4707_CR12","doi-asserted-by":"crossref","first-page":"O20","DOI":"10.1111\/codi.12805","volume":"17","author":"KI Jones","year":"2015","unstructured":"Jones KI, Doleman B, Scott S et al (2015) Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Color Dis 17:O20\u2013O26","journal-title":"Color Dis"},{"key":"4707_CR13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jss.2013.07.059","volume":"186","author":"K Ranganathan","year":"2014","unstructured":"Ranganathan K, Terjimanian M, Lisiecki J et al (2014) Temporalis muscle morphomics: the psoas of the craniofacial skeleton. J Surg Res 186:246\u2013252","journal-title":"J Surg Res"},{"key":"4707_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S (2001) Adjusting for multiple testing - when and how? J Clin Epidemiol 54:343\u2013349","journal-title":"J Clin Epidemiol"},{"key":"4707_CR15","volume":"7","author":"AHM Kilgour","year":"2012","unstructured":"Kilgour AHM, Subedi D, Gray CD et al (2012) Design and validation of a novel method to measure cross-sectional area of neck muscles included during routine mr brain volume imaging. PLoS One 7, e34444","journal-title":"PLoS One"},{"key":"4707_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13539-012-0067-5","volume":"3","author":"JM Argil\u00e9s","year":"2012","unstructured":"Argil\u00e9s JM, Busquets S, L\u00f3pez-Soriano FJ et al (2012) Are there any benefits of exercise training in cancer cachexia? J Cachex Sarcopenia Muscle 3:73\u201376","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"4707_CR17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MCO.0000000000000032","volume":"17","author":"FG Girolamo Di","year":"2014","unstructured":"Di Girolamo FG, Situlin R, Mazzucco S et al (2014) Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care 17:145\u2013150","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"4707_CR18","doi-asserted-by":"crossref","first-page":"E1967","DOI":"10.1210\/jc.2014-1271","volume":"99","author":"D Padhi","year":"2014","unstructured":"Padhi D, Higano CS, Shore ND et al (2014) Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 99:E1967\u2013E1975","journal-title":"J Clin Endocrinol Metab"},{"key":"4707_CR19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-011-0039-1","volume":"2","author":"R Dallmann","year":"2011","unstructured":"Dallmann R, Weyermann P, Anklin C et al (2011) The orally active melanocortin-4 receptor antagonist BL-6020\/979: a promising candidate for the treatment of cancer cachexia. J Cachex Sarcopenia Muscle 2:163\u2013174","journal-title":"J Cachex Sarcopenia Muscle"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-016-4707-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4707-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-016-4707-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T08:12:26Z","timestamp":1498723946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-016-4707-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4707"],"URL":"https:\/\/doi.org\/10.1007\/s00330-016-4707-6","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]}}}